EGFR and non-small cell lung carcinoma: Consecutive 5 μm sections from patient samples were tested for clinically relevant NSCLC-associated EGFR variants using the IdyllaTM EGFR Mutation Test and local reference methods; performance (concordance) and analytical turnaround time were compared.